Global Contrast Injectors Market Driven by Increasing Chronic Diseases
By MedImaging International staff writers Posted on 10 Jul 2018 |
Image: The global contrast injectors market is expected to grow over 5% during 2018-2022, driven primarily by increasing chronic diseases (Photo courtesy of Mallinckrodt/Guerbet).
The global contrast injectors market is expected to grow at a CAGR of 5.07% over the forecast period 2018-2022, driven primarily by increasing chronic diseases. In recent years, there has been a significant increase in the demand for medical devices such as contrast injectors for treating such chronic illness arising from the growing incidence of cardiovascular diseases as a result of obesity and increase in blood pressure. These are the latest findings of Research and Markets, (Dublin, Ireland), a global market research company.
A key trend in the market is the growing demand for automated contrast injectors. A number of technological advances are taking place in contrast media injector systems such as the development of automated contrast injectors, dual head, syringe-less and triple head contrast injectors, and integration of the device with the patients' database. Increasing awareness of information technology in the healthcare sector is resulting in vendors in the contrast injectors market focusing on integrating these contrast media injectors with IT systems including hospital information system (HIS), and picture archiving and communication systems (PACS). However, the high cost of contrast media injectors poses a key challenge to market growth.
Related Links:
Research and Markets
A key trend in the market is the growing demand for automated contrast injectors. A number of technological advances are taking place in contrast media injector systems such as the development of automated contrast injectors, dual head, syringe-less and triple head contrast injectors, and integration of the device with the patients' database. Increasing awareness of information technology in the healthcare sector is resulting in vendors in the contrast injectors market focusing on integrating these contrast media injectors with IT systems including hospital information system (HIS), and picture archiving and communication systems (PACS). However, the high cost of contrast media injectors poses a key challenge to market growth.
Related Links:
Research and Markets
Latest Industry News News
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures
- Global Contrast Enhanced Ultrasound Market Driven by Demand for Early Detection of Chronic Diseases